Wieslaw M Kazmierski

5PUBLICATIONS
8CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active moleculesImmunogenetics (incl. genetic immunology)Proteins and peptidesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 20, 2026
Lipophilic Ligand Efficiency-Monitored Discovery of Potent, Achiral, and Bioavailable Apo-IDO1 Inhibitors.

|Nov 18, 2021
The Discovery of Conformationally Constrained Bicyclic Peptidomimetics as Potent Hepatitis C NS5A Inhibitors.

Wieslaw M Kazmierski, Nagaraju Miriyala, David K Johnson

|Sep 25, 2020
Characterization of Apo-Form Selective Inhibition of Indoleamine 2,3-Dioxygenase*.

Rodrigo F Ortiz-Meoz, Liping Wang, Rosalie Matico

|Mar 24, 2020
GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype Coverage.

Wieslaw M Kazmierski, Sam Baskaran, Jill T Walker

|Feb 20, 2020
DNA-Encoded Library Technology-Based Discovery, Lead Optimization, and Prodrug Strategy toward Structurally Unique Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors.

Wieslaw M Kazmierski, Bing Xia, John Miller

Pageof 1

Frequent Collaborators

3 joint publications

Nagaraju Miriyala

1 joint publications

Rodrigo F Ortiz-Meoz

1 joint publications

Guofeng Zhang

1 joint publications

Zhengrong Zhu